1. Home
  2. EXAS vs PRI Comparison

EXAS vs PRI Comparison

Compare EXAS & PRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXAS
  • PRI
  • Stock Information
  • Founded
  • EXAS 1995
  • PRI 1927
  • Country
  • EXAS United States
  • PRI United States
  • Employees
  • EXAS N/A
  • PRI N/A
  • Industry
  • EXAS Medical Specialities
  • PRI Life Insurance
  • Sector
  • EXAS Health Care
  • PRI Finance
  • Exchange
  • EXAS Nasdaq
  • PRI Nasdaq
  • Market Cap
  • EXAS 8.8B
  • PRI 9.7B
  • IPO Year
  • EXAS N/A
  • PRI N/A
  • Fundamental
  • Price
  • EXAS $43.28
  • PRI $284.80
  • Analyst Decision
  • EXAS Strong Buy
  • PRI Buy
  • Analyst Count
  • EXAS 18
  • PRI 7
  • Target Price
  • EXAS $70.59
  • PRI $309.86
  • AVG Volume (30 Days)
  • EXAS 2.0M
  • PRI 191.5K
  • Earning Date
  • EXAS 05-07-2025
  • PRI 05-05-2025
  • Dividend Yield
  • EXAS N/A
  • PRI 1.27%
  • EPS Growth
  • EXAS N/A
  • PRI N/A
  • EPS
  • EXAS N/A
  • PRI 13.71
  • Revenue
  • EXAS $2,758,867,000.00
  • PRI $3,151,795,000.00
  • Revenue This Year
  • EXAS $13.02
  • PRI $2.51
  • Revenue Next Year
  • EXAS $13.02
  • PRI $4.92
  • P/E Ratio
  • EXAS N/A
  • PRI $13.49
  • Revenue Growth
  • EXAS 10.37
  • PRI 12.01
  • 52 Week Low
  • EXAS $40.62
  • PRI $184.76
  • 52 Week High
  • EXAS $79.62
  • PRI $307.91
  • Technical
  • Relative Strength Index (RSI)
  • EXAS 37.18
  • PRI 49.03
  • Support Level
  • EXAS $44.00
  • PRI $283.38
  • Resistance Level
  • EXAS $47.23
  • PRI $296.00
  • Average True Range (ATR)
  • EXAS 1.57
  • PRI 6.49
  • MACD
  • EXAS 0.09
  • PRI 0.05
  • Stochastic Oscillator
  • EXAS 23.60
  • PRI 48.67

About EXAS Exact Sciences Corporation

Exact Sciences Corporation, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a noninvasive stool-based DNA test, is a pre-cancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening, too.

About PRI Primerica Inc.

Primerica Inc is a provider of financial services to middle-income households in the United States and Canada. The company offers life insurance, mutual funds, annuities, and other financial products, distributed on behalf of third parties. Primerica has three main subsidiaries: Primerica Financial Services, a marketing company; Primerica Life Insurance Company, a principal life insurance underwriting entity; and PFS Investments, which offers investment and savings products, brokerage services, and registered investment advisory. It has four segments Term Life Insurance; Investment and Savings Products; Senior Health; and Corporate and Other Distributed Products. Geogriphically, it derives a majority of its revenue from the US.

Share on Social Networks: